Press Releases

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that Trophos organized two round-table meetings to establish the endpoints and design for...

CertiVox, an information security company, today announces it has received the Yearling category of the 2011 Bully Award, an honour presented by White Bull Summits to Europe’s leading technology, media and telecommunications (TMT) companies. The award...

Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for...

Rib-X Pharmaceuticals, Inc. announced that results from the Company's RX-04 development program will be featured today in the Novel Antimicrobial Agents poster session at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held...

Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human Use (CHMP) has clarified the label changes for pioglitazone-containing medicines recommended in July of...

The Zilver® PTX® Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration’s (FDA) Circulatory System...

Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, and Servier, the largest French privately-owned pharmaceutical company, announces today that they have signed a licence and research collaboration agreement in the field of deubiquitinating enzymes (DUBs) applied...